Literature DB >> 25229288

Epidemiological factors associated with seropositivity for toxoplasmosis in pregnant women from Gurupi, State of Tocantins, Brazil.

Marcos Gontijo da Silva1, Joseneide Teixeira Câmara2, Marina Clare Vinaud3, Ana Maria de Castro3.   

Abstract

INTRODUCTION: Knowledge of the prevalence and risk factors for Toxoplasma gondii dissemination among pregnant women is relevant because the parasite can be spread from mother to infant. The objective of this study was to assess the epidemiology and risk factors of toxoplasmosis in pregnant women from Gurupi, State of Tocantins, Brazil, from February 2012 to June 2013.
METHODS: The study population included 487 pregnant women. Sociodemographic, dietary and cultural data were collected using a standardized and validated form. Peripheral blood was collected for serologic testing using the ELISA test (IgM/IgG antibodies). The data were analyzed by comparing seropositivity with risk factors using crude and adjusted odds ratios.
RESULTS: The prevalence rate for IgG and IgM antibodies was 68.7% and 5.7%, respectively. Sociodemographic characteristics associated with toxoplasmosis risk included the following: education level ≤ 8 years (OR: 6.612; CI: 1.450-30.144), age ≥ 30 years (OR: 5.273; CI: 1.166-23.844), working outside the home (OR: 1.604; CI: 1.015-2.536), and family income of two minimum wages or lower (OR: 2.700; CI: 1.891-8.182). Regarding dietary habits, there was a significant association of seropositivity with meat intake (OR: 1.78; CI: 1.149-4.080), cutting vegetables without washing the cutting board beforehand (OR: 2.051; CI: 1.165-3.614), frequent intake of vegetables (OR: 2.051; CI: 1.368-3.006) and in natura milk intake (OR: 2.422; CI: 1.014-5.785).
CONCLUSIONS: The high prevalence rates of toxoplasmosis in Gurupi are related to age, raw meat and in natura milk intake, as well as education level, working outside the home, and poor hygienic habits during meal preparation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25229288     DOI: 10.1590/0037-8682-0127-2014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Toxoplasmosis seroprevalence in relation to knowledge and practice among pregnant women in Dhahran, Saudi Arabia.

Authors:  Salah H Elsafi; Wasaef F Al-Mutairi; Khalid M Al-Jubran; Mohamed M Abu Hassan; Eidan M Al Zahrani
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

2.  Commentary on: "Detection of Toxoplasma gondii in raw caprine, ovine, buffalo, bovine, and camel milk using cell cultivation, cat bioassay, capture ELISA, and PCR methods in Iran".

Authors:  Sonia Boughattas
Journal:  Front Microbiol       Date:  2015-03-18       Impact factor: 5.640

3.  Serological and molecular detection of Neospora caninum and Toxoplasma gondii in human umbilical cord blood and placental tissue samples.

Authors:  Pâmella Oliveira Duarte; Leandra Marla Oshiro; Namor Pinheiro Zimmermann; Bárbara Guimarães Csordas; Doroty Mesquita Dourado; Jacqueline Cavalcante Barros; Renato Andreotti
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

4.  Apicomplexan Protozoa Responsible for Reproductive Disorders: Occurrence of DNA in Blood and Milk of Donkeys (Equus asinus) and Minireview of the Related Literature.

Authors:  Stefania Perrucci; Lisa Guardone; Iolanda Altomonte; Federica Salari; Simona Nardoni; Mina Martini; Francesca Mancianti
Journal:  Pathogens       Date:  2021-01-22

5.  Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014.

Authors:  Marcos Gontijo da Silva; Marina Clare Vinaud; Ana Maria de Castro
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

6.  Toxoplasmosis and knowledge: what do the Italian women know about?

Authors:  A Martini; E Pietrafesa; B M Rondinone; S Iavicoli; S D'amelio; S Cavallero; M Bonafede
Journal:  Epidemiol Infect       Date:  2020-10-07       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.